Results 251 to 260 of about 536,995 (305)

The Prevalence of Eating Disorders and Disordered Eating in Adults Seeking Obesity Treatment: A Systematic Review With Meta‐Analyses

International Journal of Eating Disorders, EarlyView.
ABSTRACT Objective To estimate the prevalence of eating disorders and disordered eating in adults seeking obesity treatment. Method Databases, MEDLINE, Embase, and PsycINFO, were searched to 20th March 2025. Studies reporting the prevalence of eating disorders or disordered eating at presentation to obesity treatment in adults (≥ 18 years) with ...
Hannah Melville, Natalie B. Lister, Sol Libesman, Anna Lene Seidler, Hoi Yuk Cheng, Yuen Lam Kwan, Sarah P. Garnett, Louise A. Baur, Hiba Jebeile   +8 more
wiley   +1 more source

Prevalence, severity and factors of hearing loss in hemodialysis patients: A cross‐sectional study in Northern Tanzania

Eye &ENT Research, EarlyView.
Abstract Background Hearing loss, affecting 20% of the global population, disproportionately impacts low‐ and middle‐income countries, including Africa. Sensorineural hearing loss (SNHL) is prevalent among hemodialysis patients. In Tanzania, the growing number of hemodialysis patients highlights the need for hearing assessments.
Abdallah Jonas, Denis Katundu, Johnson Shayo, Petro Nsalu, Ezekiel Karuga, Kajiru Kilonzo, Peter Shija   +6 more
wiley   +1 more source

The difficult discussion on the deactivation of implantable cardioverter devices at the end of life: a systematic review

ESC Heart Failure, Volume 12, Issue 2, Page 733-760, April 2025.
Abstract Implantable cardioverter defibrillators (ICDs) reliably prevent death due to life‐threatening arrhythmias; this may become less relevant in people with more severe heart failure who are reaching the end of life (EOL). This review aimed to explore the ICD deactivation process and identify ethical issues, especially around the initiation of ...
Siobhan C. Murray, Claire McNamara, Anna V. Chatzi   +2 more
wiley   +1 more source

Forecasting heart failure: Seasonal alignment of heart failure outcomes in New York

ESC Heart Failure, Volume 12, Issue 2, Page 819-831, April 2025.
Abstract Background Seasonal variations have been observed in heart failure (HF) hospitalization. Numerous explanatory mechanisms have been proposed, but no prior studies have examined potential contributors directly. Our objective was to identify specific factors that could contribute to seasonal variability using a large longitudinal dataset of HF ...
Prerna Gupta, Ellen Brinza, Prateeti Khazanie, Pamela N. Peterson, P Michael Ho, David P. Kao   +5 more
wiley   +1 more source

Meta‐analysis of sotagliflozin, a dual sodium‐glucose‐cotransporter 1/2 inhibitor, for heart failure in type 2 diabetes

ESC Heart Failure, Volume 12, Issue 2, Page 968-979, April 2025.
Abstract Sodium‐glucose co‐transporters (SGLTs) mediate sodium and glucose transport across cell membranes. SGLT2 inhibitors have a recognized place within heart failure (HF) guidelines. We evaluated the effect of sotagliflozin on HF and cardiovascular outcomes in participants with type 2 diabetes. Scopus, Medline, Embase and Central were searched from
Maria Anna Bantounou, Panagiotis Sardellis, Josip Plascevic, Ribeya Awaes‐Mahmood, Justyna Kaczmarek, Daniel Black Boada, Rosa Thuemmler, Sam Philip   +7 more
wiley   +1 more source

Multivariate linear regression to predict association of non‐invasive arterial stiffness with cardiovascular events

ESC Heart Failure, Volume 12, Issue 2, Page 1141-1150, April 2025.
Abstract Background Arterial stiffness is a crucial factor in determining an increase in systolic blood pressure and pulse pressure and can also predict the development of cardiovascular disease (CVD). The purpose of this study was to examine the relationship between arterial stiffness and future CVD.
Susan Darroudi, Mostafa Eslamiyeh, Amin Mansoori, Eisa Nazar, Maryam Alinezhad‐Namaghi, Reza Rezvani, Majid Ghayour‐Mobarhan, Habibollah Esmaily, Mohsen Moohebati, Gordon A. Ferns, Mark Ghamsary   +10 more
wiley   +1 more source

The Role of Vitamin D in Diabetes Ketosis and Ketoacidosis

Chronic Diseases and Translational Medicine, EarlyView.
Cui Zhang, Jia Liu, Sumita Cholekho, Qin Pei, Huiwen Tan   +4 more
wiley   +1 more source

Type-2 Diabetes Mellitus: risk factors in a school in the health field

, 2000
Maria Carolina Alves Ortiz, María Lúcia Zanetti   +1 more
openalex  

Some of the next articles are maybe not open access.

Related searches:

Type 2 diabetes mellitus

Nature Reviews Disease Primers, 2015
Type 2 diabetes mellitus (T2DM) is an expanding global health problem, closely linked to the epidemic of obesity. Individuals with T2DM are at high risk for both microvascular complications (including retinopathy, nephropathy and neuropathy) and macrovascular complications (such as cardiovascular comorbidities), owing to hyperglycaemia and individual ...
DeFronzo, Ralph A, Ferrannini, Ele, Groop, Leif, Henry, Robert R, Herman, William H, Holst, Jens Juul, Hu, Frank B, Kahn, C Ronald, Raz, Itamar, Shulmann, Gerald I., Simonson, Donald C, Testa, Marcia A, Weiss, Ram   +12 more
  +9 more sources

Pioglitazone for type 2 diabetes mellitus

Cochrane Database of Systematic Reviews, 2006
Diabetes has long been recognised as a strong, independent risk factor for cardiovascular disease, a problem which accounts for approximately 70% of all mortality in people with diabetes. Prospective studies show that compared to their non-diabetic counterparts, the relative risk of cardiovascular mortality for men with diabetes is two to three and for
Susanne H Ebrahim, Bernd Richter, Karla Bergerhoff, Elizabeth Bandeira-Echtler, Christine Clar   +4 more
openaire   +3 more sources